type here...

CATEGORIES

Healthcare

LATEST

1...293031...74Page 30 of 74

TRENDING

EDITORS CHOICE

India’s Pivotal Regulatory Shift: A Possible Game-Changer in Expediting Medicines to Millions in Dire Need

Gil Bashe, Medika Life Editor -
“Go to India” May Be a Key Market for Pharma Company Growth and Global Public Health

FDA Approves New Opioid, Olinvyk, for Intravenous Use in Hospitals

Medika Life -
the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

HLTH2023 is Packed as 10,000 Attendees Fill the Halls – Special Attention on Israel

Gil Bashe, Medika Life Editor -
HLTH2023 is a big hit. But many of Israel’s 100 exhibitors head home urgently to support family and nation - while HLTH rallies to support this community.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories